The “Big Short” Guy: Don’t Be Like Warren Buffett

The “Big Short” guy learned from the teachings of Warren Buffett but reaping is the same success without emulating the legendary investor. In Canada, an attractive prospect for value investors is the Nuvei stock.

| More on:

You know Warren Buffett is a legendary investor because even big equity investment firms want to invest like him. Younger investors desire to get into Buffett’s buy-and-hold investing model and be as successful as the man. However, Michael Burry, the “big short” guy, is creating his own path to success.

Buffett is Burry’s inspiration, although he’s not following the footsteps of the GOAT of investing. He’s proving that you don’t have to be like Buffett to be an excellent stock picker.

Famous subprime trade

Michael Burry is an American physician, but became more popular because of the movie “The Big Short.” The Hollywood flick documents the events leading up to Burry’s contrarian but hugely successful bet against the U.S. real estate market in 2008. Its collapse led to the global financial crisis.

The neurologist was one of the first investors to predict correctly and profit from the subprime mortgage crisis. Burry was a virtual unknown until he made his subprime trade. He founded Scion Asset Management and is now one of the famous fund managers in the investing world.

Rare birds and robins

Like Buffett, Dr. Burry is a big-time value investor. His weapon of choice when selecting stocks is research. His investment philosophy is somewhat similar to Buffett’s. Burry is particular with the margin of safety and invests in great stocks in disfavored industries. He believes, too, that portfolio management is equally important as picking stocks.

Buffett said, “If you wait for the robins, spring will be over.” The Oracle of Omaha was referring to the market or economy historically recovering from downturns. Burry invests in “rare birds” or assets selling at less than two-thirds of net value.

A company must also show a sustainable competitive advantage and demonstrate long-standing, stable high returns on invested capital. Burry finds value in technology stocks. As of the third quarter of 2020, Scion’s stock portfolio is worth US$440 million. The top holding is Alphabet Class C (16.2% of total).

The next big tech stock

Value investors like Michael Burry should find one of Canada’s recent IPOs a promising investment for 2021. Nuvei (TSX: NVEI) debuted on the TSX in September 2020 and has performed remarkably well. As of December 18, 2020, the tech stock trades at $75.01per share or 189% higher than its initial public offering (IPO) price of $26.

Nuvei’s red-hot IPO was Canada’s largest tech offering ($833 million). The $10.36 billion company provide payment solutions for mobile and e-commerce clients in online retail and online gambling. After the successful IPO, Nuvei CEO, Philip Fayer, said, “Canada is still a good place to build a business.”

Fayer adds, “Canada has tremendous opportunity, and we’re seeing so much innovation.” He also thinks more people will bring their business online because of COVID-19. The company is on the road to profitability, and management expects a 26% average annual revenue growth over the next couple of years.

Looking for value

The award-winning movie “The Big Short” made Michael Burry famous. Today, he doesn’t care about the stock market’s level. He will invest in-large-cap, mid-cap, small-cap, and tech or non-tech stocks as long as he finds value in the companies.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Suzanne Frey, an executive at Alphabet, is a member of The Motley Fool’s board of directors. Fool contributor Christopher Liew has no position in any of the stocks mentioned. David Gardner owns shares of Alphabet (A shares) and Alphabet (C shares). Tom Gardner owns shares of Alphabet (A shares) and Alphabet (C shares). The Motley Fool owns shares of and recommends Alphabet (A shares) and Alphabet (C shares).

More on Tech Stocks

Man data analyze
Tech Stocks

3 Reasons Celestica Stock Is a Screaming Buy Now

These three reasons make Celestica stock a screaming buy for long-term investors.

Read more »

profit rises over time
Dividend Stocks

These 2 Dow Stocks Are Set to Soar in 2025 and Beyond

Two Dow Jones stocks are screaming buys but Canadians must hold them in an RRSP or RRIF to avoid paying…

Read more »

telehealth stocks
Tech Stocks

Well Health Stock: Buy, Sell, or Hold?

Another record-breaking quarter and strong demand sets the stage for continued momentum for Well Health stock.

Read more »

3 colorful arrows racing straight up on a black background.
Dividend Stocks

TSX Stocks Soaring Higher With No Signs of Slowing

Three TSX stocks continue to beat the market and could soar higher in an improving investment landscape.

Read more »

profit rises over time
Tech Stocks

2 Non-AI Tech Stocks to Buy in November for Better Returns

Not all AI stocks are riding the hype train, and for many investors, well-understood and predictable growth stocks might be…

Read more »

worry concern
Tech Stocks

In a Few Years, You’ll Probably Regret Not Owning BlackBerry Stock

Here’s why I believe BlackBerry could be one of the most overlooked Canadian tech stocks right now.

Read more »

A worker uses a double monitor computer screen in an office.
Tech Stocks

Is Constellation Software Stock a Buy for its 0.25% Dividend Yield?

Here's what investors may want to consider when it comes to Dollarama (TSX:DOL) and its relatively low dividend yield.

Read more »

Nurse talks with a teenager about medication
Tech Stocks

Shares of WELL Health Just Zoomed. Is It a Buy?

Given its improving financials and healthy growth prospects, WELL Health could deliver superior returns over the next three years.

Read more »